Quipt Home Medical announces $35M bought deal offering

Quipt Home Medical Corp. announced that it has entered into an agreement with Beacon Securities Limited and Canaccord Genuity Corp. on behalf of a syndicate of underwriters. The Underwriters have agreed to purchase, on a bought deal basis pursuant to the filing of a prospectus supplement, an aggregate of 4.46M common shares in the capital of the company at a price of $7.85 per common share for aggregate gross proceeds to the company of $35.01M. The company intends to use the proceeds of the offering for repayment of debt, potential future acquisitions, working capital and general corporate purposes. The offering is expected to close on or about April 25, 2023 and is subject to certain closing conditions including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including the approval of the TSX Venture Exchange and the applicable securities regulatory authorities.